BIO - Bio-Rad Labs Non-GAAP EPS of $2.60 misses by $0.17 revenue of $680.8M misses by $1.9M
- Bio-Rad Labs press release ( NYSE: BIO ): Q3 Non-GAAP EPS of $2.60 misses by $0.17 .
- Revenue of $680.8M (-8.9% Y/Y) misses by $1.9M .
- For the full-year 2022, the company continues to anticipate non-GAAP currency-neutral revenue growth to be at the high end of the prior 1.0 to 2.0 percent guidance, with COVID-related revenue now expected to be about $105 million versus the previous estimate of approximately $93 million. The company is reaffirming its non-GAAP operating margin expectation of approximately 19.0 percent.
For further details see:
Bio-Rad Labs Non-GAAP EPS of $2.60 misses by $0.17, revenue of $680.8M misses by $1.9M